The accurate assessment of ovarian and adnexal lesions is critical in ensuring proper treatment and minimising unnecessary surgical interventions. Before 2015, the management of these lesions often relied heavily on surgery due to the uncertainty surrounding their malignancy potential. However, the introduction of the Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound (US) scoring system has transformed the landscape of diagnostic imaging by offering a structured and evidence-based approach to stratify the risk of malignancy in ovarian lesions. This system enables healthcare providers to make more informed decisions regarding whether surgery is warranted or if conservative management can be pursued.
Role of O-RADS in Risk Stratification
The American College of Radiology introduced the O-RADS US scoring system to standardise the reporting and evaluation of ovarian and adnexal lesions. The scoring system uses ultrasound imaging features that help categorise lesions according to their malignancy risk. Lesions are scored from O-RADS 1 to O-RADS 5, with higher scores indicating a greater likelihood of malignancy. For example, a lesion categorised as O-RADS 2 is deemed to have a less than 1% chance of being malignant, while a lesion with an O-RADS 5 score is associated with over a 50% chance of malignancy.
One of the key strengths of the O-RADS system is its ability to provide a negative predictive value (NPV) of 98% for lesions categorised as benign (O-RADS 2), ensuring that lesions with low risk of malignancy can be confidently monitored without immediate surgical intervention. As a result, patients with benign lesions may avoid surgery altogether, thus reducing the health risks associated with surgical procedures, such as early menopause and infertility, which are particularly concerning for younger women. Studies have shown that O-RADS can predict ovarian cancer with high sensitivity, particularly in early-stage disease, providing a reliable alternative to surgery for many patients.
Retrospective Studies Highlight Potential for Conservative Management
A retrospective multicentre study examined the impact that O-RADS US could have had on surgical resection rates if it had been implemented earlier. This study involved 377 patients with adnexal lesions who underwent surgery between 2011 and 2014, before the introduction of O-RADS. After retrospectively assigning O-RADS scores to these lesions, the study revealed that 42% of the lesions that had been surgically removed would have been categorised as O-RADS 2 under the new system. Among these lesions, 54% were non-neoplastic, 45% were benign neoplasms, and less than 1% were malignant. These findings underscore the potential for O-RADS to reduce unnecessary surgeries by identifying patients who could safely avoid invasive procedures and instead be managed with imaging follow-up.
The study also demonstrated that using an O-RADS US score of 4 as the threshold for malignancy could provide a sensitivity of 94% and a specificity of 64%. This high sensitivity indicates that the O-RADS system can reliably detect malignant lesions, ensuring that patients who truly require surgery for malignant lesions are appropriately referred. However, the specificity was somewhat lower, suggesting that further refinement of the scoring system or the incorporation of other diagnostic tools, such as MRI, could improve the accuracy of distinguishing between benign and malignant lesions.
Reducing Patient Anxiety and Healthcare Costs
Implementing the O-RADS US scoring system has significant implications beyond reducing unnecessary surgeries. By offering a more conservative management approach, O-RADS helps to alleviate patient anxiety related to the possibility of surgery, particularly in cases where the likelihood of malignancy is low. In addition to minimising surgery's physical and emotional toll, the system also reduces healthcare costs associated with surgical procedures, postoperative care, and potential complications. For instance, the study revealed that 72% of O-RADS 5 lesions were malignant, meaning that surgery would still be necessary in these high-risk cases, but in lower-risk categories, such as O-RADS 2, conservative management could be a viable and safer option.
Moreover, O-RADS's ability to accurately stratify lesions based on risk enables gynaecologists and oncologists to offer tailored treatment plans for their patients. This personalised approach not only leads to better patient outcomes but also optimises resource allocation in healthcare systems by reducing unnecessary use of surgical services. In the context of ovarian cancer, early detection remains critical, and the O-RADS system helps rationalise the decision-making process, allowing for timely intervention when necessary while preventing unnecessary surgeries for benign lesions.
The Ovarian-Adnexal Reporting and Data System (O-RADS) US scoring system has revolutionised the management of ovarian and adnexal lesions by providing a reliable framework for assessing the risk of malignancy. Retrospective studies demonstrate that its implementation could have spared many patients from undergoing unnecessary surgeries by accurately identifying benign lesions that can be safely monitored. With a high sensitivity for detecting malignant lesions, O-RADS also ensures that patients with a high risk of malignancy are appropriately referred for surgery. The adoption of O-RADS represents a crucial step in reducing patient anxiety, improving outcomes, and optimising resource utilisation.
Source: Radiology
Image Credit: iStock
